Vitamin K2 (menaquinone-7, MK-7)
DEVitamin K2 (Menachinon-7, MK-7)
Menaquinone-7 is a long-chain form of vitamin K2 in which the side chain has seven isoprene units, giving it a longer half-life than vitamin K1 (phylloquinone) or MK-4. Like other vitamin K vitamers, it serves as a cofactor for the gamma-carboxylation of Gla proteins, including osteocalcin (bone) and matrix Gla protein (vascular wall). Dietary sources are limited: natto (a Bacillus subtilis-fermented soy food) is by far the richest, with smaller amounts in cheese and fermented dairy. In a 3-year RCT in 244 postmenopausal women, 180 microgram MK-7 daily slowed loss of vertebral height and bone mineral density. The EU has authorised vitamin K claims for normal blood coagulation and maintenance of normal bones; cardiovascular outcome evidence remains inconsistent.
Sources
- Knapen MHJ, Drummen NE, Smit E, Vermeer C, Theuwissen E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. *Osteoporosis International*doi:10.1007/s00198-013-2325-6
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2009). Scientific opinion on the substantiation of health claims related to vitamin K and maintenance of normal bone and normal blood coagulation. *EFSA Journal*doi:10.2903/j.efsa.2009.1228
- Jadhav N, Ajgaonkar S, Saha P, Gurav P, Pandey A, Basudkar V, Gada Y, et al.. (2022). Molecular pathways and roles for vitamin K2-7 as a health-beneficial nutraceutical: challenges and opportunities. *Frontiers in Pharmacology*doi:10.3389/fphar.2022.896920
